Correlation Between Catalyst Pharmaceuticals and Bright Scholar

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Bright Scholar at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Bright Scholar into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Pharmaceuticals and Bright Scholar Education, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Bright Scholar and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Bright Scholar. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Bright Scholar.

Diversification Opportunities for Catalyst Pharmaceuticals and Bright Scholar

-0.13
  Correlation Coefficient

Good diversification

The 3 months correlation between Catalyst and Bright is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Bright Scholar Education in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bright Scholar Education and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Bright Scholar. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bright Scholar Education has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Bright Scholar go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and Bright Scholar

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 0.75 times more return on investment than Bright Scholar. However, Catalyst Pharmaceuticals is 1.33 times less risky than Bright Scholar. It trades about -0.01 of its potential returns per unit of risk. Bright Scholar Education is currently generating about -0.09 per unit of risk. If you would invest  2,134  in Catalyst Pharmaceuticals on August 24, 2024 and sell it today you would lose (19.00) from holding Catalyst Pharmaceuticals or give up 0.89% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Catalyst Pharmaceuticals  vs.  Bright Scholar Education

 Performance 
       Timeline  
Catalyst Pharmaceuticals 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Catalyst Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
Bright Scholar Education 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bright Scholar Education has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Catalyst Pharmaceuticals and Bright Scholar Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Catalyst Pharmaceuticals and Bright Scholar

The main advantage of trading using opposite Catalyst Pharmaceuticals and Bright Scholar positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Bright Scholar can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bright Scholar will offset losses from the drop in Bright Scholar's long position.
The idea behind Catalyst Pharmaceuticals and Bright Scholar Education pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.